Stockscreener 앱 받기
10.72
0.00%
0.00
시간 외 거래:
10.74
0.02
+0.19%
전일 마감가:
$10.72
열려 있는:
$10.75
하루 거래량:
53,904
Relative Volume:
0.55
시가총액:
$234.85M
수익:
-
순이익/손실:
$6.21M
주가수익비율:
37.81
EPS:
0.2835
순현금흐름:
$-682.00K
1주 성능:
-0.28%
1개월 성능:
+0.85%
6개월 성능:
+2.49%
1년 성능:
+4.60%
1일 변동 폭
$10.72
$10.76
1주일 범위
$10.70
$10.80
52주 변동 폭
$10.25
$10.80
Translational Development Acquisition Corp Stock (TDAC) Company Profile
명칭
Translational Development Acquisition Corp
전화
(413) 204-2769
주소
52 E 83RD ST., NEW YORK
Compare TDAC vs LION, XXI, UMAC, DMII, BCSS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TDAC
Translational Development Acquisition Corp
|
10.72 | 234.85M | 0 | 6.21M | -682.00K | 0.2835 |
LION
Lionsgate Studios Corp
|
13.92 | 3.98B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.72 | 1.85B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
25.72 | 1.09B | 17.25M | -5.64M | -40.16M | -0.3337 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.08 | 642.73M | 0 | 8.58M | -1.11M | 0.134 |
BCSS
Bain Capital Gss Investment Corp
|
10.23 | 596.27M | 0 | 8.29M | -686.50K | 0.142 |
Translational Development Acquisition Corp Stock (TDAC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-09-21 | 개시 | Northland Capital | Outperform |
Translational Development Acquisition Corp 주식(TDAC)의 최신 뉴스
ProLogium’s public listing is set to close in the second half of 2026 — valuing the only mass-production solid-state battery line on Earth at about $3.8 billion - MSN
TDACW Warrants Hold Steady at $1.55 as Trading Range TightensRounding Top - newsline.com
ProLogium to list on Nasdaq via TDAC merger at $3.8B valuation - MSN
Translational Development Acquisition Corp. Warrants (TDACW) Surge 10.71% on Renewed Speculative InterestCommon Gap - newsline.com
ProLogium details tech, 800k cells shipped and TDAC tie‑up (TDAC) - Stock Titan
Linden Advisors/Linden GP disclose 950,000-share stake in TDAC (TDAC) - Stock Titan
Battery maker ProLogium to list on Nasdaq in $3.8 billion SPAC deal - MSN
Number of shareholders of Translational Development Acquisition Corp. – NASDAQ:TDACW - TradingView
ProLogium Set for Nasdaq Debut in $3.8 Billion SPAC Deal - Electric Cars Report
Solid-state battery pioneer ProLogium to go public in $3.8 billion deal - MSN
Leapfrog Acquisition holds near $10 with SPAC deadline on the horizon - Bez Kabli
ProLogium: $3.8 Billion SPAC Deal To Take Solid-State Battery Developer Public On Nasdaq - Pulse 2.0
TDAC (TDAC) CEO Michael Hoffman purchases 53,395 company warrants in open market - Stock Titan
Scanianew under-cab battery module and Megawatt Charging System now available for order - Batteries News
McKinley Acquisition Stock Flat at $10 as $176.7M Deal Waits - Bez Kabli
Imperii Acquisition hovers at $10 as SPAC traders turn their focus back - Bez Kabli
Aldel Financial II Stock Barely Moves, But Its SPAC Clock Is Ticking - Bez Kabli
Translational Development Acquisition Corp. Warrants (TDACW) Surge 7.84% as Bulls Test ResistancePut Flow Alert - The Legal Advocate
RF Acquisition Corp III Trades Around $10 as SPAC Deals Spotlight RFAM - Bez Kabli
ProLogium targets SPAC merger to fund French battery plant - electrive.com
ProLogium to go public via SPAC merger at $3.8B valuation - Investing.com UK
SC II Acquisition Stock Stays Flat as $10 Price Holds Attention - Bez Kabli
ProLogium to go public via SPAC merger at $3.8B valuation By Investing.com - Investing.com India
Translational Development (TDAC) plans SPAC merger deadline extension vote - Stock Titan
3 Firms Steer Battery Maker ProLogium's $3.8B SPAC Merger - Law360
Another solid-state EV battery maker is going public to fund its next growth stage - Electrek
Prologium Holdings Inc. agreed to acquire Translational Development Acquisition Corp. (NasdaqGM:TDAC.U) from TDAC Partners LLC for approximately $3.8 billion in a reverse merger transaction. - marketscreener.com
Solid-state battery maker ProLogium to go public in $3.8 billion deal - Automotive News
Translational Development Acquisition, ProLogium to Combine in $3.8 Billion Transaction - Moomoo
Translational Development Acquisition, ProLogium Announce Nasdaq Merger - TipRanks
ProLogium Picks A SPAC Route To List In New York - Finimize
Translational Development Acquisition to Merge With ProLogium in SPAC Deal Valuing Target at $3.8 Billion - TradingView
TDAC merges with ProLogium, combined company to list as PRLG (PRLG) - Stock Titan
Solid-state battery maker ProLogium, TDAC (NASDAQ: TDAC) plan $3.8B merger - Stock Titan
ProLogium, a Next Generation Solid-State Battery Developer - GlobeNewswire
BreezeBio Announces Scientific Advisory Board to Support Next Stage of Precision Genetic Medicine Pi - pharmiweb.com
BreezeBio Forms Scientific Advisory Board as Precision Genetic Medicine Pipeline Advances - citybiz
Translational Development Acquisition Corp. (TDAC) Edges Lower, Consolidates Near Key SupportPro Level Trade Signals - Newser
Translational Development Acquisition Corp. (TDAC) Holds Steady Near Resistance as Trading Volume Remains MutedMcClellan Summation - Newser
BlossomHill Therapeutics Expands Board of Directors with the Appointments of Sheila Gujrathi, M.D., and John Schmid - The Manila Times
Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer - NTB Kommunikasjon
TRIANA Biomedicines Adds Veteran Drug Developer Mohan Bala as COO Amid Molecular Glue Push - citybiz
Translational Development Acquisition Corp (TDAC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
0.12%
자본화:
|
볼륨(24시간):